EVLARCO
Live / Allowed — Publication / registration review complete (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99782125
- Mark type
- Design + words
- Filed
- 23 Apr 2026
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Michelle Rosenberg
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, Lewy body dementia, and Alzheimer's disease
Owner
- NewAmsterdam Pharma B.V., Naarden, NL
Prior registrations
Prosecution history
- 31 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Aug 2026 — ASSIGNED TO EXAMINER
- 30 Aug 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 30 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Apr 2026 — NEW APPLICATION ENTERED